Scemblix 40 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F6CT4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,956
Award facts
- Contract value 100% obligated
- $15,956.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,956.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the delivery of Scemblix 40 mg tablets in quantities of 60 units. The order is scheduled for completion by February 3, 2026, with performance taking place in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, allowing AmerisourceBergen to compete on a full and open basis. The contract represents a task order issued under a larger Indefinite Delivery Contract vehicle supporting federal pharmaceutical procurement needs.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (UEI: NWEGNLYTBDW4), a major pharmaceutical distributor serving military and federal healthcare systems. This award falls under AmerisourceBergen's significant IDC with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to military treatment facilities, the Defense Health Agency, and other government healthcare systems worldwide. Scemblix, an oncology medication, aligns with the company's portfolio of specialty medications and brand-name drugs delivered through the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F6CT4?
SPE2DR26F6CT4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F6CT4 worth?
The government has obligated $15,956 on SPE2DR26F6CT4.
Is contract SPE2DR26F6CT4 an order under another contract?
Yes. SPE2DR26F6CT4 is a delivery order under SPE2DR25D1052, an indefinite delivery contract.
Was contract SPE2DR26F6CT4 competed?
The extent of competition for SPE2DR26F6CT4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award